Navigation Links
Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group

Merger provides additional value to clients, shareholders and employees

CARY, N.C., March 2 /PRNewswire/ -- ASG, Inc. - a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.

The acquisition - completed in early February for an undisclosed amount of stock - enables ASG to expand the breadth and value of services it provides clients needing to outsource clinical research trials; it also equips its clients in the pharmaceutical industry with a robust package of functional outsourcing and staffing services as well as a new opportunity to outsource an entire clinical trial.

"The addition of the Ockham team and its services helps accelerate our goal of becoming the company of choice for those wishing to outsource or augment staffing of a clinical trial," said ASG President and CEO James Baker. "We now have the breadth of services that allows clients to one-stop shop if they so desire."

In completing the acquisition, ASG is fulfilling a portion of its global growth strategy that will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

"The ASG platform will make it possible for Ockham to scale its operations and extend its client reach into a true global presence," said Ockham CEO, Dr. Josh Baker (unrelated), who now leads the company's clinical research organization operations. "This is a unique opportunity to combine with a stable industry leader and quickly build market value."

About ASG:

ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, ASG provides flexible solutions that satisfy client needs through highly experienced recruiting and dedicated functional support teams located throughout the world.

About Ockham Development Group:

Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina. Staffed by veteran industry professionals with a track record of proven results, it is centrally located near the university-technology-biotech / pharmaceutical sciences nexus known internationally as Research Triangle Park (RTP).

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
2. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
3. Implicit Licenses Clinical Stage Antibody Program From Lilly
4. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
5. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
6. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
7. M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference
8. Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit
9. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
10. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
11. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
Breaking Biology News(10 mins):